Evidence map›Paper›PMID 40251829›Full record

ArticleBriefings in bioinformatics2025

DMGAT: predicting ncRNA-drug resistance associations based on diffusion map and heterogeneous graph attention network.

Tingyu Liu, Qiuhao Chen, Renjie Liu, Yuzhi Sun, Yadong Wang, Yan Zhu, Tianyi Zhao

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tingyu LiuSchool of Medicine and Heath, Harbin Institute of Technology, 150000, Nangang District, Xidazhi Street No. 90, Harbin, China.
Qiuhao ChenZhengzhou Research Institute, Harbin Instituteof Technology, 150000, Nangang District, Xidazhi Street No. 90, Harbin, Heilongjiang, China.
Renjie LiuZhengzhou Research Institute, Harbin Instituteof Technology, 150000, Nangang District, Xidazhi Street No. 90, Harbin, Heilongjiang, China.
Yuzhi SunSchool of Computer Science and Technology, Harbin Institute of Technology, 150000, Nangang District, Xidazhi Street No. 90, Harbin, Heilongjiang, China.
Yadong WangSchool of Computer Science and Technology, Harbin Institute of Technology, 150000, Nangang District, Xidazhi Street No. 90, Harbin, Heilongjiang, China.ORCID 0000-0001-6500-6217
Yan ZhuCollege of Veterinary Medicine, Northeast Agricultural University, 150038, Xiangfang District, Changjiang Road No. 600, Harbin, China.
Tianyi ZhaoSchool of Medicine and Heath, Harbin Institute of Technology, 150000, Nangang District, Xidazhi Street No. 90, Harbin, China.ORCID 0000-0003-1913-081X

Funding

National key R&D plan 2022YFF1202101
6 · The paper itself

Abstract

Non-coding RNAs (ncRNAs) play crucial roles in drug resistance and sensitivity, making them important biomarkers and therapeutic targets. However, predicting ncRNA-drug associations is challenging due to issues such as dataset imbalance and sparsity, limiting the identification of robust biomarkers. Existing models often fall short in capturing local and global sequence information, limiting the reliability of predictions. This study introduces DMGAT (diffusion map and heterogeneous graph attention network), a novel deep learning model designed to predict ncRNA-drug associations. DMGAT integrates diffusion maps for sequence embedding, graph convolutional networks for feature extraction, and GAT for heterogeneous information fusion. To address dataset imbalance, the model incorporates sensitivity associations and employs a random forest classifier to select reliable negative samples. DMGAT embeds ncRNA sequences and drug SMILES using the word2vec technique, capturing local and global sequence information. The model constructs a heterogeneous network by combining sequence similarity and Gaussian Interaction Profile kernel similarity, providing a comprehensive representation of ncRNA-drug interactions. Evaluated through five-fold cross-validation on a curated dataset from NoncoRNA and ncDR, DMGAT outperforms seven state-of-the-art methods, achieving the highest area under the receiver operating characteristic curve (0.8964), area under the precision-recall curve (0.8984), recall (0.9576), and F1-score (0.8285). The raw data are released to Zenodo with identifier 13929676. The source code of DMGAT is available at https://github.com/liutingyu0616/DMGAT/tree/main.

Indexed as

Computational BiologyDeep LearningDrug ResistanceRNA, UntranslatedAlgorithmsHumansRNA, Untranslateddiffusion mapgraph attention networkgraph convolution networkncRNA-drug resistance association prediction

Identifiers

PMID40251829
PMCPMC12008124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.